Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis

被引：0
|
作者：
Wong, Robert J. [1 ]
Kachru, Nandita [2 ]
Meyer, Nicole [3 ]
Gordon, Stuart C. [4 ]
机构：
[1] Highland Hosp, Alameda Hlth Syst, Div Gastroenterol & Hepatol, Oakland, CA USA
[2] Gilead Sci, Foster City, CA USA
[3] Truven Hlth Analyt, Cambridge, MA USA
[4] Henry Ford Hlth Syst, Detroit, MI USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2268
引用
收藏
页码：1283A / 1284A
页数：2
相关论文
共 50 条
  • [1] Increasing Healthcare Resource Utilization (HCRU) and Costs Associated with Advanced Liver Disease - a Multivariate Analyses of Real-World Medicare Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients
    Gordon, Stuart C.
    Fraysse, Jeremy
    Li, Suying
    Wong, Robert J.
    HEPATOLOGY, 2018, 68 : 573A - 573A
  • [2] Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients with advanced liver disease had high burden of comorbidities, healthcare resource utilization (HCRU) and costs: results from Italian administrative databases
    Marchesini, G.
    Ting, J.
    Saragoni, S.
    Esposti, L. Degli
    Ozbay, A. B.
    Petta, S.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E27 - E27
  • [3] Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
    Romero-Gomez, Manuel
    Kachru, Nandita
    Zamorano, Meritxell Ascanio
    Darba, Josep
    Shreay, Sanatan
    MEDICINE, 2020, 99 (50) : E23506
  • [4] Longitudinal Analyses of Comorbidities and Healthcare Costs Among Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease
    Harrison, Stephen A.
    Kachru, Nandita
    Parker, Emily
    Korrer, Stephanie
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 572A - 573A
  • [5] Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy
    Petta, Salvatore
    Ting, Jie
    Saragoni, Stefania
    Degli Esposti, Luca
    Shreay, Sanatan
    Petroni, Maria Letizia
    Marchesini, Giulio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (06) : 1014 - 1022
  • [6] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [7] Fibrosis-4 Score (FIB-4) Provides Consistent Assessment of Healthcare Costs and Healthcare Resource Utilization (HCRU) Among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis
    Gordon, Stuart C.
    Ozbay, Burak
    Parker, Emily
    Korrer, Stephanie
    Wong, Robert J.
    HEPATOLOGY, 2018, 68 : 617A - 618A
  • [8] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
  • [9] Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in Patients with Morbid Obesity
    Manno, Emilio
    OBESITY SURGERY, 2010, 20 (06) : 811 - 811
  • [10] Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Gerhardt, Florian
    Petroff, David
    Blank, Valentin
    Boehlig, Albrecht
    van Boemmel, Florian
    Wittekind, Christian
    Berg, Thomas
    Karlas, Thomas
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 706 - 711
12345